| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
17.300 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
APC |
IPI00215877 |
17.300 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
17.300 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
TIMP2 |
TIMP2: Metalloproteinase inhibitor 2 precursor |
17.290 |
Evidence |
|
| YWHAQ |
YWHAQ: 14-3-3 protein theta |
EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
17.290 |
Evidence |
|
| STXBP1 |
IPI00046057 |
VAMP3 |
VAMP3, SYB3: Vesicle-associated membrane protein 3 |
17.230 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
17.210 |
Evidence |
|
| RNPS1 |
RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
17.210 |
Evidence |
|
| GNB2L1 |
Lung cancer oncogene 7 |
EIF4G2 |
EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 |
17.210 |
Evidence |
|
| SNRPD3 |
SNRPD3: Small nuclear ribonucleoprotein Sm D3 |
TOP2A |
TOP2A, TOP2: DNA topoisomerase 2-alpha |
17.210 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
CASP8 |
IPI00305242 |
17.210 |
Evidence |
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
AHR |
AHR: Aryl hydrocarbon receptor precursor |
17.210 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
PTMA |
IPI00015550 |
17.210 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
BAZ1B |
BAZ1B, WBSC10, WBSCR10, WBSCR9, WSTF: Bromodomain adjacent to zinc finger domain |
17.210 |
Evidence |
|
| CTPS |
CTPS: CTP synthase 1 |
ESPL1 |
IPI00397474 |
17.210 |
Evidence |
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
17.210 |
Evidence |
|
| CPB1 |
CPB1, CPB, PCPB: Carboxypeptidase B precursor |
REG3A |
REG3A, HIP, PAP, PAP1: Regenerating islet-derived protein 3 alpha precursor |
17.210 |
Evidence |
|
| UNG |
IPI00011069 |
PTMA |
IPI00015550 |
17.210 |
Evidence |
|
| UNG |
IPI00011069 |
PRKDC |
PRKDC, HYRC, HYRC1: DNA-dependent protein kinase catalytic subunit |
17.210 |
Evidence |
|
| XRCC6 |
XRCC6, G22P1: ATP-dependent DNA helicase 2 subunit 1 |
UNG |
IPI00011069 |
17.210 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
17.210 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
17.210 |
Evidence |
O
|
| PLEK |
PLEK, P47: Pleckstrin |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
17.210 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
17.210 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
H2AFX |
H2AFX, H2AX: Histone H2A.x |
17.210 |
Evidence |
|